References
1. Choudhary U, Aggarwal R. ESBL – An Emerging threat to clinical theraputics. Indian journal of Medical Microbiology. 2004;Vol.22(2):P 75-80
2. Ibukun A, Tochukwn N, Tolu O. Occurance of ESBL and MBL in clinical isolates of Pseudomonas aeruginasa from Lagose, Nigeria. Journal of American Science. 2007;3(4): 81-85.
3. Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: A clinical update. Clin Microbiol Rev.2005;18:657–86).
4. Kluytmans J. Surgical infection including burns. In: Wenzel RP,editor. Prevention and control of nosocomial infections. 3rd ed. Baltimore:Williams and Wikins;1997. P.841-65.
5. Arora D, Jindal N,Kumar R, Romit. Emerging Antibiotic Resistance In Pseudomonasa Challenge. International Journal Of Pharmacy And Pharmaceutical Sciences Issn- 0975-1491 Vol 3, Issue 2, 2011
6. Fleggo, P & Opoku, S “AmpC beta lactamases production among Pseudomonas aeruginosa & Proteus mirabilus isolates at the komfo Anokye teaching hospital, Kumasi, Ghana. Journal of medical microbiology antimicrobial 2014; 6(1): 13-20.
7. Anurava K, Sreenivisan S, Kumar et al “Detection of Metello beta lactamases producing Pseudomonas aeruginosa in intensive care unit” Journal list > Australas med J > 2013; 6(12) : 686-693.
8. Kalant E, Torabsi V, Salimizad H, Soheili F. “ Incidence and susceptibility pattern of metello beta lactamases producers among Pseudomonas aeruginosa isolated from burns patients at Kurdistan province. Jundispur microbial. 20i2; 5(3):507-510
9. Farida A, Mir A. Susceptibility pattern of Pseudomonas aeruginosa against various antibiotics. African Journal of Microbiology Research. 2010; 4(10): 1005-1012
10. Kumar V, Sen MR, Anupurba S, Prakash P, Gupta R. An observational study of metallo-beta-lactamase production in clinical isolates of Pseudomonas aeruginosa: an experience at tertiary care hospital in North Iindia. Indian J. Prev. Soc. Med. 2011; 42(2): 173-6.
11. Jacoboson K L, Cohen S H, Inciardi J F et al “The relation between antecedent antibiotic use & resistance to extended spectrum cephalosporins in group beta lactamases producing organism.” Clin infect dis 1995 nov; 21(5):1107-15.
12. Sharma M, Pathak S, Srivastava P. Prevalence and antibiogram of Extended Spectrum β-Lactamase (ESBL) producing Gram negative bacilli and further molecular characterization of ESBL producing Escherichia coli and Klebsiella spp., Journal of Clinical and Diagnostic Research. 2013 Oct; 7(10): 2173-2177.
13. Usha K, E. Kumar, Dvr. Sai Gopal. Occurrence Of Various Beta-Lactamase Producing Gram Negative Bacilli In The Hospital Effluent Asian Journal Pharmaceutical And Clinical Research 2013; 6(3)
14. Franco MRG, Caiaffa-Filho HH, Burattini M N, Rossi F. Metallo beta lactamases among Imipenem-resistant Pseudomonas aeruginosa in a Brazilian university hospital. Clinics. 2010; 65(9): 825-9.
15. Juyal D, Prakash R, Shanakarnarayan SA, Sharma M, Negi V, Sharma N. Prevalence of nonfermenting gram negative bacilli and their in vitro susceptibility pattern in a tertiary care hospital of Uttarakhand. A study from foothills of Himalayas. Saudi Journal for Health Sciences. 2013; 2(2): 108-112
16. Rajput A , Prajapati B, Chauhan B, Shah A, Trivedi , Kadam “Prevalence of Metallo-betalactamases (MBL) producing Pseudomonas aeruginosa in a Tertiary care Hospital.” Indian Journal of Basic & Applied Medical Research; September 2012: Vol.-1, Issue-4, P. 304-308
17. Jacoboson K L, Cohen S H, Inciardi J F et al “The relation between antecedent antibiotic use & resistance to extended spectrum cephalosporins in group beta lactamases producing organism.” Clin infect dis 1995 nov; 21(5):1107-15.
18. Upadhyay S, Sen MR, Bhattacharjee A. Presence of different beta lactamase class among Clinical isolates of Pseudomonas aeruginosa expressing AmpC beta lactamase enzyme. Department of Microbiology, Institute of Medical Science, Banaras Hindu university Varanasi, India. 2010;4(4) :239-292.
19. Peshattiwar D P, Virupaksappa. ESBL and MBL mediated resistance in Psedomonas aeruginosa: An emerging threat to clinical therapeutic. Journal of Clinical and Diagnostic Research. 2011 dec; 5(8):1552-1554
20. Aggarwal R, Chaudhary U, Balak. “Detection of Extended spectrum beta lactamases in Pseudomonas aeruginosa” Indian s pathol microbial. 2008;51(2):222-4.
21. Uma devi S, Joseph NM, Kumari K, et al., Detection of ESBL, AmpC and MBL in clinical isolates of ceftazidine in Pseudomonas aeruginosa. Braz. J. Microbiol. 2011;42
22. Mehta M, Punia JN, Joshi RM. Antibiotic resistant in Pseudomonas aeruginosa strain isolated from various clinical specimens. Indian Journal Medical Microbiol. 2001;19:232.
23. Shoorashetty RM, Nagarathnamma T, Prathibha. Comparison of the boronic acid disk potentiation test and cefepime–clavulanic acid method for the detection of ESBL among AmpC-producing Enterobacteriaceae, Indian Journal of Medical Microbiology, 2011; 29(3): 297-301
24. Rawat V, Singhai M. Detection of different beta lactamases and their co-existance by various disc combination method in clinical isolates of Enterobactericeae and Pseudomonas. Journal of Laboratory Physician. 2013;5(1):21-5.
25. Salami F, Eftekhar f “Coexistence of AmpC and Extended-Spectrum β-lactamases in Metallo-β-Lactamase Producing Pseudomonas aeruginosa Burn Isolates in Tehran. Jundishapur Journal of Microbiology. 2013 October; 6(8): e7178.
DOI: https://dx.doi.org/10.18535/jmscr/v5i1.54
